HomeBUSINESS
BUSINESS

Bayer Yakuhin Finds 85 Further Cases of Unreported ADRs
(Aug.2.2017)

Bayer Yakuhin announced on July 31 that it has failed to report 85 cases of adverse drug reactions (ADRs) to regulatory authorities. After delays in ADR case reports for Xarelto (rivaroxaban) were discovered, the company conducted an internal investigation for all the drugs it sells. The investigation confirmed further omissions in ADR reporting ...
(LOG IN FOR FULL STORY)

News Calendar